Stem cell sources for allogeneic stem cell transplantation / Ahmed Mostafa Lotfy Abouelnasr ; Supervised Fouad A. Elnawawy , Mona M. Elkassas , Alaa M. Elhaddad
Material type: TextLanguage: English Publication details: Cairo : Ahmed Mostafa Lotfy Abouelnasr , 2008Description: 140 P. ; 25cmOther title:- مصادر الخلايا الجذعية المتاحة لعمليات زرع النخاع العظمي من متبرع [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.18.M.Sc.2008.Ah.S (Browse shelf(Opens below)) | Not for loan | 01010110050454000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.18.M.Sc.2008.Ah.S (Browse shelf(Opens below)) | 50454.CD | Not for loan | 01020110050454000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
Cai01.11.18.M.Sc.2008.Ah.R Relation of asymmetric dimethylariginine(ADMA)to different stages of nephropathy in diabetic patients / | Cai01.11.18.M.Sc.2008.Ah.R Relation of asymmetric dimethylariginine(ADMA)to different stages of nephropathy in diabetic patients / | Cai01.11.18.M.Sc.2008.Ah.S Stem cell sources for allogeneic stem cell transplantation / | Cai01.11.18.M.Sc.2008.Ah.S Stem cell sources for allogeneic stem cell transplantation / | Cai01.11.18.M.Sc.2008.Am.B Bcr - abl mutations in chronic myeloid leukemia / | Cai01.11.18.M.Sc.2008.Am.B Bcr - abl mutations in chronic myeloid leukemia / | Cai01.11.18.M.Sc.2008.Am.I Inflammatory bio-markers and cerebrovascular disease risk / |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine
HLA-matched related allogeneic stem cell transplantation (SCT) has been successfully used as the treatment of choice in selected high-risk or recurrent hematologic malignancies, marrow failure syndromes, severe congenital immunodeficiency states, and selected metabolic disorders
Issued also as CD
There are no comments on this title.